Arbutus Biopharma Corpora... (ABUS)

ABUS trades at $3.42, 14.0% above the near-term max pain of $3 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$4), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ABUS shows a downward trend from 4 to 2.5, indicating bearish sentiment or hedging activity. The 47% spread signals divergent expectations across timeframes. Levels distributed around 3.42. Strong magnetic level at 3 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.